Survival Rates for Pancreatic Cancer: The American Cancer Society (2022) [cited 2022 11 May]. Available from: https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/survival-rates.html
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Bengtsson A, Andersson R, Ansari D (2020) The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data. Sci Rep 10(1):16425
Article PubMed PubMed Central Google Scholar
Klatte DCF, Boekestijn B, Onnekink AM, Dekker FW, van der Geest LG, Wasser M et al (2023) Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis. Gastroenterol 164(7):1223-1231.e4
Rawla P, Sunkara T, Gaduputi V (2019) Epidemiology of pancreatic cancer: global Trends, etiology and risk factors. World J Oncol 10(1):10–27
Article PubMed PubMed Central Google Scholar
Stoffel EM, Brand RE, Goggins M (2023) Pancreatic cancer: changing epidemiology and new approaches to risk Assessment, early Detection, and prevention. Gastroenterology 164(5):752–765
Petersen GM (2016) Familial pancreatic cancer. Semin Oncol 43(5):548–553
Article PubMed PubMed Central Google Scholar
Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY et al (2018) Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319(23):2401–2409
Article CAS PubMed PubMed Central Google Scholar
Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK et al (2020) Management of patients with increased risk for Familial pancreatic cancer: updated recommendations from the international cancer of the pancreas screening (CAPS) consortium. Gut 69(1):7–17
Article CAS PubMed Google Scholar
Blackford AL, Canto MI, Dbouk M, Hruban RH, Katona BW, Chak A et al (2024) Pancreatic cancer surveillance and survival of High-Risk individuals. JAMA Oncol 10(8):1087–1096
Article PubMed PubMed Central Google Scholar
Kasi GMA (2024) Familial Adenomatous Polyposis. StatPearls
Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV et al (1993) Increased risk of thyroid and pancreatic carcinoma in Familial adenomatous polyposis. Gut 34(10):1394–1396
Article CAS PubMed PubMed Central Google Scholar
Karstensen JG, Bülow S, Højen H, Jelsig AM, Jespersen N, Andersen KK et al (2023) Cancer in patients with Familial adenomatous polyposis: A nationwide Danish cohort study with matched controls. Gastroenterology 165(3):573–81e3
Sawhney MS, Calderwood AH, Thosani NC, Rebbeck TR, Wani S, Canto MI et al (2022) ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc 95(5):817–826
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW (2015) ACG clinical guideline: genetic testing and management of hereditary Gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223–262 quiz 63
Article PubMed PubMed Central Google Scholar
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK et al (2017) The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA: A cancer. J Clin 67(2):93–99
Hug L, Alexander M, You D, Alkema L (2019) National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis. Lancet Glob Health 7(6):e710–e20
Article PubMed PubMed Central Google Scholar
Patterson KN, Trout AT, Shenoy A, Abu-El-Haija M, Nathan JD (2022) Solid pancreatic masses in children: A review of current evidence and clinical challenges. Front Pediatr 10:966943
Article PubMed PubMed Central Google Scholar
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496–509
Sasieni PD, Shelton J, Ormiston-Smith N, Thomson CS, Silcocks PB (2011) What is The lifetime risk of developing cancer? The effect of adjusting for multiple primaries. Br J Cancer 105(3):460–465
Article CAS PubMed PubMed Central Google Scholar
UK CR Our calculations explained [Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/cancer-stats-explained/our-calculations-explained#heading-Eight
Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I et al (2013) International cancer of the pancreas screening (CAPS) consortium summit on the management of patients with increased risk for Familial pancreatic cancer. Gut 62(3):339–347
Vietri MT, D’Elia G, Caliendo G, Albanese L, Signoriello G, Napoli C et al (2022) Pancreatic cancer with mutation in BRCA1/2, MLH1, and APC genes: phenotype correlation and detection of a novel germline BRCA2 mutation. Genes (Basel) 13(2):321
Olaoba OT, Adelusi TI, Yang M, Maidens T, Kimchi ET, Staveley-O’Carroll KF et al (2024) Driver mutations in pancreatic cancer and opportunities for targeted therapy. Cancers (Basel) 16(10):1808
Maurer E, Lehman B, Matthäi E, Denzer U, Figiel J, Jesinghaus M et al Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant-negative Familial pancreatic cancer families. United Eur Gastroenterol J 12(9):1211-1221
Ben-Aharon I, Elkabets M, Pelossof R, Yu KH, Iacubuzio-Donahue CA, Leach SD et al (2019) Genomic landscape of pancreatic adenocarcinoma in younger versus older patients: does age matter? Clin Cancer Res 25(7):2185–2193
Comments (0)